Elos Medtech AB: Elos Medtech Interim Report January 1 - June 30, 2023
April - June 2023
- Net sales for the second quarter amounted to SEK 269.8 (233.1) million, an increase of 15.8 percent compared to the same quarter last year. Net sales in local currencies increased by 9.5 percent.
- Operating profit amounted to SEK 30.1 (37.8) million, corresponding to an operating margin of 11.2 (16.2) percent.
- Profit after net financial items amounted to SEK 13.7 (38.8) million. Net financial items were negatively affected by exchange rate differences of SEK -8.6 (3.6) million and totaled SEK -16.4 (1.1) million.
- Cash flow from operating activities was SEK 34.6 (26.4) million, and SEK 2.0 (-3.8) million after investments.
- Earnings per share amounted to SEK 1.16 (3.68).